The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
HypertensionCongestive Heart Failure
Interventions
DRUG

valsartan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY